Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Clinical trial NCT00445419 · COMPLETED

Trial details

NCT number: NCT00445419
Sponsor: Pevion Biotech Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2006-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.